Understanding the biological processes that precede death is critical for making informed clinical decisions and facilitating care transitions. Here, we analyzed routine clinical data of 292,576 patients from two large hospital cohorts in Germany and the United States to identify temporal patterns at the end of life.
Integrating comprehensive laboratory values, vital signs, and ICD codes, we identified consistent, multisystem trajectories of terminal decline that were conserved across age, sex, and diagnostic subgroups. Changes largely occurred in an orchestrated pattern, beginning with electrolyte imbalances, followed by hepatic and renal dysfunction, progressive vital sign deterioration, and culminating in coagulation failure. Based on internal data from over 80,000 deceased and non-deceased patients, we developed a diagnosis-agnostic machine learning model to predict 90-day mortality risk using 27 routine clinical parameters and 15 disease groups. The prediction model had a high accuracy on internal data (AUC: 0.86) and generalized well to an external cohort of 211,527 hospitalized patients (AUC: 0.79).
Our results provide a data-driven foundation for understanding end-of-life pathophysiology and demonstrate the potential of routine hospital data to inform individualized care planning.
Competing Interest StatementThe authors have declared no competing interest.
Funding StatementJ.Keyl is supported by a German Research Foundation (DFG)-funded clinician scientist program (FU 356/12-2).
Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Ethics Committee of the Medical Faculty of the University Duisburg-Essen (No. 22-10881-BO). The requirement for written informed consent was waived due to the retrospective design of the study and the deidentification of data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Comments (0)